Cargando…
Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
BACKGROUND: The alkylating agent Dacarbazine (DTIC) has been used in the treatment of melanoma for decades, but when used as a monotherapy for cancer only moderate response rates are achieved. Recently, the clinical use of Temozolomide (TMZ) has become the more commonly used analog of DTIC-related o...
Autores principales: | Thangasamy, Thilakavathy, Sittadjody, Sivanandane, Mitchell, Geoffrey C, Mendoza, Erin E, Radhakrishnan, Vijayababu M, Limesand, Kirsten H, Burd, Randy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895613/ https://www.ncbi.nlm.nih.gov/pubmed/20540768 http://dx.doi.org/10.1186/1471-2407-10-282 |
Ejemplares similares
-
Tyrosinase Overexpression Promotes ATM-Dependent p53 Phosphorylation by Quercetin and Sensitizes Melanoma Cells to Dacarbazine
por: Thangasamy, Thilakavathy, et al.
Publicado: (2008) -
IGF1 activates cell cycle arrest following irradiation by reducing binding of ΔNp63 to the p21 promoter
por: Mitchell, G C, et al.
Publicado: (2010) -
Relative expression of TAp73 and ΔNp73 isoforms
por: Conforti, Franco, et al.
Publicado: (2012) -
Quercetin as an Emerging Anti-Melanoma Agent: A Four-Focus Area Therapeutic Development Strategy
por: Harris, Zoey, et al.
Publicado: (2016) -
DEC1 Coordinates with HDAC8 to Differentially Regulate TAp73 and ΔNp73 Expression
por: Qian, Yingjuan, et al.
Publicado: (2014)